4th Quarter - Report
HOLLAND & KNIGHT LLP for KCI USA, INC.
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Competitive Bidding Program; CBIC Round 2 decisions; S.2312, DME Access and Stabilization Act of 2015; H.R. 5210 & S.2736, Patient Access to DME Act of 2016; 21st Century Cures Act (2016).
Foreign entity interest: As the private equity owners of KCI USA, Inc., the interests of Chiron B1 S.a.r.l. Luxembourg, CPP Investments Board Private Holdings, Inc., and Port-Aux-Choix Private Investments, Inc., identified on form LD-1, are aligned with those of KCI USA, Inc.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL S. BOCK | — |
| KERRY FEEHERY | — |
| SHAWNA FRANCIS WATLEY | — |
| MICHAEL M GABA | — |
| KARL KOCH | — |
| KATHRYN H LEHMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.